FANCI Antibody
KIAA1794/FLJ10719 is also known as Fanconi anemia group I protein (FANCI). KIAA1794/FLJ10719 has been identified as the gene underlying Fanconi anemia (FA) complementation group I, an autosomal recessive disorder characterized by a predisposition to malignancies, pancytopenia, and a diverse assortment of congenital malformations. KIAA1794/FLJ10719 has been demonstrated to function in the repair of DNA double-stranded breaks and the maintenance of chromosomal stability.
Alternative names for FANCI Antibody include FLJ10719 antibody, KIAA1794 antibody.
| Product/Catalog # | Specifications | Price |
|---|---|---|
| FANCI Antibody A301-254A | Reactivity:
Human Applications: WB, IP |
$314.00 Bulk Quote Data Sheet Add to Cart |
| KIAA1794/FLJ10719 Antibody A300-212A | Reactivity:
Human Applications: WB, IP |
$314.00 Bulk Quote Data Sheet Add to Cart |
| KIAA1794/FLJ10719 Antibody A300-213A | Reactivity:
Human Applications: WB |
$314.00 Bulk Quote Data Sheet Add to Cart |
| KIAA1794 Antibody AbVantage™ Pack A310-059A | Applications:
WB, IP Reactivity: Human Quantity: 1 each of A300-212A and A300-213A |
$437.00 Bulk Quote Data Sheet Add to Cart |
Reviews
Quick Order
Pathways
Featured Collections
- Actin Cytoskeleton
- ATM-ATR Signaling
- COMT and Schizophrenia
- Condensin Complex
- ErbB2 Pathway in Breast Cancer
- GTPase Regulation
- Homologous Recombination
- Inflammation and Cancer
- IRF8 Implications in Disease & Development
- Jumonji and Cancer
- MAPs
- Methylation and Memory Formation
- Mitosis and Cell Cycle Progression
- mTOR
- Mutant EGFR analysis by PLA
- NF-kappa B
- Nucleoporin
- Novel Cancer Biomarkers
- Stat Signaling and Cancer
- SWI/SNF-like
- Translation Initiation
- USP
- WD-repeat
- Wnt Signaling
- XP
Every Bethyl product ships with a 100% guarantee; choose Bethyl antibodies with confidence.
